Journal Title：Minerva Cardiology And Angiology

Minerva Cardiology And Angiology, as an internationally peer-reviewed academic journal, plays an important role in the field of cardiovascular disease. This journal is committed to becoming a bridge for cardiovascular researchers, clinical doctors, and scholars to exchange the latest scientific discoveries and clinical practices. We also attach great importance to the management and rehabilitation strategies of cardiovascular diseases, including drug therapy, interventional therapy, surgical procedures, and lifestyle adjustments. The journal encourages the publication of innovative treatment methods and clinical trial results to promote progress in the treatment of cardiovascular diseases.

The journal covers the entire spectrum of cardiovascular diseases, from basic epidemiological research exploring the distribution and influencing factors of diseases to in-depth pathophysiological research revealing the biological mechanisms underlying disease occurrence. In addition, the journal also focuses on diagnostic methods for cardiovascular diseases, including the latest imaging techniques, biomarkers, and clinical tests, as well as risk stratification, to help doctors assess the severity and future risks of patients' diseases.

《Minerva Cardiology And Angiology》作為一份國際同行評審的學術期刊，它在心血管疾病領域扮演著重要的角色。該期刊致力于成為心血管醫學研究者、臨床醫生和學者之間交流最新科學發現和臨床實踐的橋梁。同樣重視心血管疾病的管理和康復策略，包括藥物治療、介入治療、外科手術以及生活方式的調整。期刊鼓勵發表創新的治療方法和臨床試驗結果，以促進心血管疾病治療的進步。

期刊內容涵蓋了心血管疾病的全譜系，從基礎的流行病學研究，探索疾病的分布和影響因素，到深入的病理生理學研究，揭示疾病發生的生物學機制。此外，期刊還關注心血管疾病的診斷方法，包括最新的影像學技術、生物標志物和臨床測試，以及風險分層，幫助醫生評估患者的疾病嚴重程度和未來風險。

Minerva Cardiology And Angiology由Edizioni Minerva Medica出版商出版，收稿方向涵蓋CARDIAC & CARDIOVASCULAR SYSTEMS全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發表機率較高。平均審稿速度 ，影響因子指數1.4，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。